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Abstract
Purpose To evaluate the effect of a new-generation positional device, the sleep position trainer (SPT), in non-apneic position-
dependent snorers.
Methods Non-apneic position-dependent snorers with an apnea–hypopnea index (AHI) < 5 events/h were included between 
February 2015 and September 2016. After inclusion, study subjects used the SPT at home for 6 weeks. The Snore Outcome 
Survey (SOS) was filled out by the subjects at baseline and after 6 weeks, and at the same time, the Spouse/Bed Partner 
Survey (SBPS) was filled out by their bed partners.
Results A total of 36 participants were included and 30 completed the study. SOS score improved significantly after 6 weeks 
from 35.0 ± 13.5 to 55.3 ± 18.6, p < 0.001. SBPS score also improved significantly after 6 weeks from 24.7 ± 16.0 versus 
54.5 ± 25.2, p < 0.001. The severity of snoring assessed with a numeric visual analogue scale (VAS) by the bed partner 
decreased significantly from a median of 8.0 with an interquartile range (IQR) of [7.0–8.5] to 7.0 [3.8–8.0] after 6 weeks 
(p = 0.004).
Conclusions Results of this study indicate that positional therapy with the SPT improved several snoring-related outcome 
measures in non-apneic position-dependent snorers. The results of this non-controlled study demonstrate that this SPT could 
be considered as an alternative therapeutic option to improve sleep-related health status of snorers and their bed partners.
Keywords Non-apneic snoring · Positional therapy · Primary snoring · Habitual snoring · Position-dependent snoring · 
Sleep position trainer
Introduction
Snoring is the result of airflow passing through the upper 
airway, which in turn causes vibrations in the soft tissues. 
It is indicative of increased resistance in the upper airway 
and is often associated with obstructive sleep apnea (OSA) 
[1–4]. The prevalence of snoring in the general population is 
between 20 and 60%, depending on the definition, measure-
ments, and population variables. Significant gender differ-
ences are observed with an higher prevalence in men than 
in women [1, 5–9]. Non-apneic snoring or primary snor-
ing is defined as snoring with less than five apneic and/or 
hypopneic events per hour of sleep. Primary (self-reported) 
snoring could, just like OSA, be associated with excessive 
daytime sleepiness and negative sleep pattern behaviors 
[6, 10, 11]. Some research suggests that self-reported non-
apneic snoring also has important clinical implications such 
as increased risk for cardiovascular disease [12, 13]. Besides 
these comorbidities affecting the primary snorer, snoring 
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can also have negative impact on the sleep quality of the 
bed partner [14–17]. Habitual loud snoring may result in 
couples choosing to sleep apart or resort to using earplugs 
to counteract the sound [14]. These aspects can have a nega-
tive impact on the psychosocial aspects and the intimacy in 
a couple’s relationship, and even may trigger marital dishar-
mony or result in divorce [1].
Sleeping position can influence the severity of snoring; 
however, few studies have looked at position dependency in 
non-apneic snorers. Nakano et al. found that snoring time 
and snoring intensity were lower in the lateral position than 
in the supine position in non-apneic snorers [18]. Choi et al. 
described that in non-apneic snorers, snoring decreased 
when a subject adopted a non-supine position [19]. A ret-
rospective study performed by Benoist et al. looked at posi-
tion dependency in non-apneic snorers seeking clinical care 
and found that 65.8% of this group is position dependent 
[20]. These results are in line with studies performed in OSA 
patients, which show position dependency to be inversely 
related to disease severity [21, 22]. Approximately 56% of 
patients with mild OSA is position dependent, defined as 
having at least twice as many events in supine position com-
pared to the other sleeping positions, while in severe OSA 
position dependency only occurs in 6% [21, 23–25]. Hence, 
the proportion of position dependency may be highest in 
non-apneic snorers, followed by mild and moderate OSA, 
and lowest in severe OSA.
Positional therapy (PT) is one of the treatment options for 
positional OSA (POSA) patients. Van Maanen et al. showed 
that PT with a new positional device, the Sleep Position 
Trainer (SPT), effectively reduces disease severity in mild-
to-moderate POSA [26, 27]. PT has also been compared 
to oral appliances, and short- and long-term results show 
similar efficacy in mild-to-moderate POSA patients [28, 
29]. Since the majority of non-apneic snorers are position 
dependent, these subjects may potentially benefit from PT. 
The aim of this study was, therefore, to evaluate the effect of 
the SPT in position-dependent non-apneic snorers.
Methods
Study design
This study was conducted in the OLVG West hospital 
(Amsterdam, the Netherlands) after approval from the local 
ethical committee. Non-apneic snorers were recruited for 
this study. According to the ICSD-3 criteria, patients had 
no complaints of insomnia, excessive daytime sleepiness, or 
sleep disruption attributable to snoring; moreover, a diag-
nostic polysomnography (PSG) to rule out OSA was per-
formed. After informed consent, subjects received the SPT, 
which they had to use during sleep for a period of 6 weeks. 
Study subjects and bed partners filled out questionnaires at 
baseline and after 6 weeks of using the SPT.
Polysomnography
PSG was performed in the Sleep Laboratory of OLVG West 
using a digital PSG (Embla A10, Broomfield, CO, USA). 
During an overnight stay, various parameters were meas-
ured. To define the apnea–hypopnea index (AHI), airflow 
was measured using a sensor in the nasal cannula. Snoring 
was assessed using a nasal cannula and a piezo element sen-
sor attached to the cricoid. These sensors detected snoring 
sounds lasting longer than 300–3000 ms. This resulted in 
an index of snoring events per hour, which could be differ-
entiated between the various sleeping positions. Sleeping 
position was registered using a position sensor (Sleepsense, 
St Charles, IL, USA). This sensor was placed at the midline 
of the abdomen to discriminate between the different posi-
tions: supine, lateral right, lateral left, prone, and upright 
position. The recorded data were analyzed using special 
software (Somnologica™ studio) and manually edited. To 
exclude OSA patients, an apnea was defined as the cessation 
of nasal airflow of more than 90% for a period of 10 s or 
longer in the presence of respiratory efforts. In accordance 
with the prevailing definition from the American Academy 
of Sleep Medicine (AASM) at that time, a hypopnea was 
scored whenever there was a greater than 30% reduced oro-
nasal airflow for at least 10 s, accompanied by ≥ 4% oxygen 
desaturation from pre-event baseline. Non-apneic snorers 
were defined as subjects with a snoring index > 1 and an 
AHI < 5/h sleep.
Inclusion criteria
Subjects were included after undergoing a full-night PSG 
under suspicion of OSA in the period between February 
2015 and September 2016 at the OLVG West Hospital, 
Amsterdam, the Netherlands. The inclusion criteria were as 
follows: adult subjects with a bed partner; AHI < 5 events 
per hour of sleep; supine sleeping position between 10 and 
90% of total sleep time (TST); and the snoring was posi-
tion-dependent according to PSG records. This latter was 
calculated using the snoring index, which is defined as the 
frequency of snoring: the number of snore events per hour 
of sleep. Supine-dependent snoring was defined as a supine 
snoring index higher than the total non-supine snoring index. 
The main exclusion criterion was previous therapy with the 
SPT.
Primary outcomes
To measure the severity of snoring and the impact 
to patients’ quality of life, a validated subjective 
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questionnaire was used: the Snore Outcome Survey (SOS) 
and the Spouse/Bed Partner Survey (SBPS) [30]. The SOS 
comprises eight questions on a 5-point Likert scale that 
evaluated the duration, frequency, severity, and conse-
quences of problems associated with sleep-disordered 
breathing (SDB), and snoring in particular [Cronbach’s 
α = 0.672 (pre), 0.748 (post)]. To evaluate the impact of 
snoring on the bed partner, the SBPS was used. This ques-
tionnaire consists of three items on a 5-point Likert scale 
and assesses the effect of the snoring on the bed partner 
[Cronbach’s α = 0.868 (pre), 0.731 (post)]. The SOS and 
SBPS scores range from 0 (worst) to 100 (best) [30].
Secondary outcomes
Secondary outcomes were the severity of snoring and sat-
isfaction using the SPT. To evaluate the severity of snor-
ing, a numeric visual analogue scale (VAS) containing 
a score between 1 (no snoring) and 10 (severe snoring) 
was filled out by the bed partners, at baseline and after 
6 week of using the SPT. The study subjects were asked 
a dichotomous question (containing yes or no) about 
satisfaction using the SPT for a period of 6 weeks. Fur-
thermore, according to the study by Lee et al. response 
profiles were determined; VAS ≤ 3 post-treatment was 
defined as ‘major response’ and post-treatment VAS ≤ 5 
plus SOS ≥ 60 defined as ‘fine response’ [31].
Intervention: the sleep position trainer
The SPT is a lightweight and small device (72 × 35 × 10 mm, 
25 g), which is worn around the chest with a neoprene strap 
(Fig. 1). A three-dimensional digital accelerometer is used 
to determine body position. When lying in supine position, 
a subtle vibration is provided to give feedback to the user. 
The self-adaptive device gradually increases the intensity of 
the vibration until the user turns to a non-supine position. 
The vibration is adapted to the user in duration, strength, and 
pattern to maintain a timely response by the subject. Vari-
ous phases are integrated for subjects to familiarize with the 
device: an analysis phase, a build-up phase, and a training 
phase (Fig. 2).
Statistical analysis
For the analyses, different descriptive statistics and inferen-
tial statistics were used.
The SOS questionnaire test survey items use a Likert 
scaling model scoring system between 0 and 4. The sum 
score of the eight items, per individual score of the subject, 
could vary between 0 and 32. Total sum score was rescaled 
to an overall score between 0 and 100. If one question was 
left blank, scores were rescaled from 0 to 28 to overall scores 
between 0 and 100. However, when more than one item was 
left blank, SOS scores were treated as missing. The SBPS 
containing a Likert-scale model between 0 and 3 items that 
was rescaled to an overall score between 0 and 100 [30].
Categorical variables were expressed as n (%). Continu-
ous normally distributed variables were presented by their 
mean and standard deviation and non-normally distributed 
data by their median and interquartile range for skewed dis-
tributions. Normally distributed continuous unpaired data 
were tested with the independent samples Student’s t test 
and in case of skewed data, with the independent samples 
Mann–Whitney U test. Normally distributed continuous 
paired data were tested with the dependent samples Stu-
dent’s t test and in case of skewed data, with the Wilcoxon 
signed-rank test. Per-protocol analyses were completed for 
all outcome parameters. Significance level was set at p value 
Fig. 1  Sleep position trainer
Fig. 2  Various phases of the sleep position trainer. The analysis phase 
contains the first two nights in which no active feedback was given to 
the user. In the build-up phase, the next seven nights, the SPT started 
to vibrate in an increasing amount of episodes of supine position. 
During the training phase, night ten and onwards, the SPT vibrated 
every time a supine position was detected. If the subject did not react, 
the vibrations start again after a pause of 2 min
 European Archives of Oto-Rhino-Laryngology
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of 0.05. Statistical analysis was performed using IBM SPSS 
statistical package 24.0.
Results
A total of 36 subjects were included in the study. Six sub-
jects (five males and one female) did not complete the fol-
low-up and were excluded. Baseline characteristics of the 
30 subjects who completed the study are shown in Table 1.
SOS and SBPS scores
All individual scores are presented in Table 2. Complete 
sets of the SOS scores were collected in n = 19 study sub-
jects. Another six subjects had missing data on one SOS 
item, for which we corrected. SOS data from a total of 25 
subjects were available for analysis. SOS score in these sub-
jects improved significantly from 35.0 ± 13.5 to 55.3 ± 18.6 
(p < 0.001) after 6 weeks of SPT therapy. Total SBPS score 
(n = 24/30) also improved significantly from 24.7 ± 16.0 to 
54.5 ± 25.2, p < 0.001.
VAS score and satisfaction
Severity of snoring assessed by the bed partner (n = 29) 
decreased significantly from a median VAS score of 8.0 
[7.0–8.5] to 7.0 [3.8–8.0] after 6 weeks (p = 0.004). Fur-
thermore, 81.5% (n = 22/27) of the subjects reported that 
they were satisfied with the use of the SPT.
Response rates
Twenty-four percent of the study subjects (n = 7/29) reported 
a VAS ≤ 3 after 6 weeks (‘major response’). A VAS ≤ 5 was 
seen in 34.5% (n = 10/29) and 36.0% (n = 9/25) had a SOS 
score ≥ 60.
A combination of VAS ≤ 5 and SOS score ≥ 60 was 
reported in four subjects 16.7% (‘fine response’).
Discussion
This is the first prospective study investigating the effect of 
the SPT on position-dependent non-apneic snorers. After 
6 weeks of therapy, we found a socially relevant improve-
ment in the sleep-related health status of snorers and their 
bed partners, combined with high satisfaction rates assessed 
by the bed partners. VAS scores evaluating the severity of 
snoring on 10-point numeric scale did show a reduction as 
reported by the bed partners. However, since it reduced only 
by 1 point (8.0–7.0), we did not find a clinically relevant 
response. Although not all response rates were high, we 
found considerable improvements in the primary outcomes.
Non-apneic snoring is a prevalent problem with clinical 
and social implications. Since the literature suggests that 
a 68% of snorers are position dependent, new-generation 
PT could be very promising. There are several studies that 
have looked at the effect of PT in apneic snorers using old-
generation positional devices: tennis ball techniques and 
pillows. Chen et al. studied whether a head-positioning pil-
low could reduce snoring sounds in patients with mild and 
moderate positional OSA. They found a significant reduc-
tion in VAS scale from 5.0 to 4.0 and snoring index from 
218.0 events/h to 115.0 events/h [32]. These results are in 
line with the findings of our study where the VAS score also 
decreased with one point after therapy (from 8.0 to 7.0). 
Choi et al. studied the effect of PT using an inflatable vest-
type device, in position-dependent snorers, with or without 
mild OSA [19]. A relevant effect was defined as a > 50% 
reduction of snoring rate in lateral position compared with 
the snoring rate in supine position. They found a significance 
decrease in snoring rate from 36.7 to 15.7%. Zuberi et al. 
also reported a significant reduction in snoring in patients 
with POSA treated with a triangular pillow [33]. In a study 
by Wenzel et al., patients with POSA were treated with a 
vest preventing the supine position [34]. A significance dif-
ference was found in snoring time (% of total sleep time) 
from 15.4 to 9.8%. However, there were other studies that 
did not find an improvement in snoring in apneic patients 
using PT [35–37]. We only found one study that evaluated 
the effect of PT in non-apneic snorers [38]. They used an 
anti-snoring pillow in primary snorers. Results reported that 
the snoring index significantly reduced from 269.0 to 162.5 
and the mean snoring index was reduced by 39.6%. In the 
current study, only subjective parameters were evaluated and 
results showed that both SOS and SBPS scores improved 
significantly after 6 weeks.
There are not many other treatments available for posi-
tional or non-positional non-apneic snoring. Since snoring 
Table 1  Patient characteristics at baseline inclusion
IQR interquartile range, BMI body mass index, TST total sleep time, 
AHI apnea–hypopnea index
Characteristics Baseline N = 30
Median [IQR]
Age (years) 41.5 [34.0_51.3]
Gender, male no. (%) 15 (50)
BMI (kg/m2) 25.0 [22.5–28.3]
AHI (events/h) 2.5 [1.2–3.4]
% supine sleep of TST 40.3 [24.7–50.4]
Supine snore index 414.8 [252.8–699.5]
Non-supine snore index 205.9 [115.7–503.9]
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is regarded a social but non-medical condition, treatment 
is usually not reimbursed. Upper airway surgery for snor-
ing can theoretically be applied, but often is overaggres-
sive, irreversible, expensive, and not reimbursed [39]. Oral 
appliance therapy can be considered. However, it is often not 
reimbursed in non-apneic snoring. The effect of a cheaper 
option, the “boil and bite” oral device is often suboptimal, 
and not predictive of the effect of expensive custom-made 
titratable devices. Oral devices might have side effects 
such as painful jaws in the morning, dry mouth or hyper-
salivation, and long-term changes in occlusion. One-third of 
patients has a contra-indication for oral device therapy [40]. 
In case of insufficient effect or serious side effects, the con-
siderable amount of money the patient has invested is lost. 
Continuous positive airway pressure (CPAP) can improve 
or eliminate snoring. Sériès et al. found that nasal CPAP 
(NCPAP) improves snoring in non-apneic snorers. In the 
NCPAP group, the snoring index decreased from 387/h to 
320/h after therapy [41]. However, due to its low compli-
ance, the limited acceptance, and high cost, CPAP is almost 
never used in the treatment of snoring [39]. Hence, PT in 
position-dependent non-apneic snoring may hold prom-
ising potential and results from the current study further 
highlight this potential. The SPT has been tested before in 
mild-to-moderate POSA patients by Van Maanen et al. and 
showed encouraging short and long-term results [26, 27]. 
These promising results in OSA patients were in line with 
other studies [28, 42]. The advantages of new-generation PT 
include that, in case it is not effective after a trial period, the 
device can be returned and side effects are limited.
Major limitations of our study are the uncontrolled 
design, the small cohort size, subjective outcome measures, 
and the short follow-up period. We report on short-term (6 
weeks) effects, while a long-term effect is not investigated. 
However, from our experience with the SPT in OSA, we 
know that the long-term effect of the SPT remains stable 
[29]. Accurate measurement of objective snoring is difficult 
and for this study not possible. Furthermore, both a stand-
ardized definition of position-dependent snoring and strict 
and precise outcome measures to evaluate effect of anti-
snoring treatment are lacking. The explanation for this is 
probably that non-apneic snoring is mostly a social problem, 
in contrast to OSA, which is a medical condition. This has 
made the necessity to determine objective snoring outcome 
measures less urgent and subjective outcomes more appro-
priate. Still, various parameters have been suggested in the 
literature to quantify snoring. But by far, the most relevant 
outcome in snoring is patient and bed partner satisfaction. 
To further define objective outcome measures and its effect 
on position-dependent non-apneic snorers, a large, prospec-
tive, longitudinal study is needed along with more long-term 
compliance data to truly assess the efficacy of PT in primary 
snoring.
Conclusions
Due to the high prevalence of snoring in the general popula-
tion and the associated negative mental and physical conse-
quences, new therapeutic options are needed. The results of 
this study indicate that PT with the SPT improved several 
outcome measures in non-apneic position-dependent snor-
ers. However, this non-controlled study has a short follow-
up, so future studies are needed to review a controlled study 
design with longer follow-up period.
The results of this non-controlled study demonstrate that 
this SPT could potentially be considered as an alternative 
therapeutic option in the treatment regime of positional pri-
mary snorers.
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